$ODD It looks like Brand No. 4 might be focusing on the hottest subject right now: anti-aging and peptides. They even hinted at using iPSC differentiation (adult cells reprogrammed back to an embryonic-like state, to develop into specific, specialized somatic cell types).
I wonder which is the winner in the degenerate bet category... Paramount offering $100B for Warner Bros. when their own market cap is only $11B? 🫠 Or $HIMS, wanting to take on Big Pharma by yelling proudly worldwide that they are breaking the law?
$DUOL The bear case for Duolingo seems to be now, not only the AI takeover, but also the alleged easiness of replicating their model, leading to an avalanche of competition. Is it really that easy, though... What do you think?
$HIMS vs Ro
January is the month of transformation and weight loss goals, which should have translated into a massive traffic win for Hims. It didn’t happen. What should we expect for the rest of the year?
$ODD My calculations show a 13% M/M traffic increase for Methodiq. While the growth looks higher initially, it's actually moderated by a shift in traffic between their two domains: methodiq and methodiqacne.
Why it’s not clicking on TikTok:
Price barrier: $69 is a lot for a TikTok "scroll-and-buy."
Psychology: Younger audiences prioritize "wants" over "needs."
Trust: A "need" product isn't glamorous; it requires a refined space, not a loud feed.
$ODD It appears the TikTok influencer campaigns aren't the ROI goldmine they likely expected for Methodiq.
Since the September launch, they’ve had exactly one viral hit (3M+). Meanwhile, their Instagram following is rapidly catching up to TikTok. Screenshots taken one week apart